Key facts
- Notable investors include Shenzhen Jiadaogu Investment Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Jingyang Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Jingyang Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jingyang Biotechnology
Manufacturer of biopharmaceutical reagents and diagnostic assay solutions aims to support precision healthcare and laboratory innovation. The company's offerings feature advanced molecular diagnostic kits, custom assay development services, and integrated reagent manufacturing capabilities, helping research institutions, clinical laboratories, and biotech firms achieve reliable testing, accurate data, and scalable workflows, enabling efficient deployment of next-generation diagnostic technologies across medical and scientific settings.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Jingyang Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jingyang Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jingyang Biotechnology in its N-PORT filings yet. We sweep new filings monthly.